Reuters logo
BRIEF-Abivax expands antiviral portfolio with program for treating Zika Virus
April 11, 2017 / 6:01 PM / 5 months ago

BRIEF-Abivax expands antiviral portfolio with program for treating Zika Virus

April 11 (Reuters) - Abivax SA:

* Announces expansion of its portfolio of antiviral drug candidates with a program for treatment of Zika Virus infections Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below